Integrated Kidney Care of the West, LLC
KCE Located In: New Mexico and Texas
Participant Groups and Providers
AMARILLO NEPHROLOGY ASSOCIATES PA
ADAN GONZALEZ
CHIYYARATH SREENIVASAN
DANIEL HENDRICK
ESTHER IHEUKWUMERE
SHELLY ELAM
EL PASO KIDNEY SPECIALISTS PA
FERNANDO RAUDALES
GERMAN HERNANDEZ
ILEANA MARTINEZ
JAIME GONZALEZ
JORGE SERNA
LAURA HERRERA
MONICA CEPEDA
OSCAR YEE
RAMESH KOMARAGIRI
SIMON RODRIGUEZ
KIDNEY SPECIALISTS OF NEW MEXICO, PC
AMBERLEIGH MORRISH
CHRISTINE CHEN
EDUARDO ALAS
UNIVERSITY OF UTAH HEALTH
MIKLOS MOLNAR
Preferred Groups and Providers
VILLAGEHEALTH DM LLC
ALEXA ACOSTA
ANDRES NIETO
DIANA CORREIA
ELIZABETH OLMOS-CASTANEDA
ESTHER NYARKO
JESSICA MCELHENNY
JESSICA VASIREDDY
JUDITH ROMAN
JULIANA IGE-ODUNUGA
KIMBERLY ELLIS
LAARNI MENDOZA
OLUBUNMI BANJO
SANDRA WATSON
YAIMA MELENDREZ GARCIA
Clinical and Administrative Leadership
Michelle Gressett
Primary Contact & Administrative Leader
Senior Director, DaVita IKC
Dan Hendrick
KCE Clinical Leader
Amarillo Nephrology Associates Pa
Quality Measures
Information for the following performance measures will be available by February 1st, 2024.
- The Depression Response measure is a patient-reported outcome measure that assesses the percentage of adult patients (18 years of age or older) who score >9 on the Patient Health Questionnaire (PHQ-9), have a diagnosis of major depression or dysthymia and who demonstrate a response to treatment at approximately 12 months.
- The Patient Activation Measure (PAM) licensed through Insignia Health (a Phreesia company), assesses the attitudes, motivators, and behaviors that allow a patient to manage his or her healthcare issues. Patient activation is essential to achieving improved health outcomes and cost control.
- Optimal ESRD Starts quantifies the ability of healthcare providers to prepare patients for ESRD by educating them and their families about the need for dialysis or kidney transplant, helping them to make appropriate and informed choices about their treatment modality, and supporting them in successfully transitioning to dialysis or kidney transplantation as kidney function declines.
Shared Savings and Losses
Information for the following performance measures will be available by February 1st, 2024.
- Total amount of Shared Savings or Shared Losses per Performance Year
- Proportion of Shared Savings invested in the program and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries
- Proportion of Shared Savings to KCE Participants and Preferred Providers for each Performance Year

For a full list of facilities and joint ventures, please click here.

For more information on CKCC, click here.